改革开放以来中医药文化发展的演进与特点探析＊

中医药文化是中医药事业发展的根基和灵魂，社会主义文化建设的重要组成。本文考察改革开放40年以来中医药文化发展的演进过程，从“社会矛盾—政策方针—中医药文化发展”的中观视角，构建了中医药文化发展分析模型，发现中医药文化先后经历了资产化发展（1978年-21世纪初）、情景化发展（21世纪初-中国共产党第十八次全国代表大会（中共十八大）前后）、生态化发展（中共十八大至今）三个阶段，每个阶段中医药文化发展的策略、重点和面临的问题具有明显的不同特点。因此，本文提出以社会矛盾为导向，优化政策引导，构建中医药文化生态体系，从个人、社会和国家发展的不同层面采取多元双向发展路径，推进健康中国发展，提升文化自信，打造文化强国。     

Comparative efficacy of first-line ceritinib and crizotinib in advanced or metastatic anaplastic lymphoma kinase-positive non-small cell lung cancer: an adjusted indirect comparison with external controls

Objective: In the absence of head-to-head trials, this study indirectly compared progression free survival (PFS) and overall survival (OS) between ceritinib and crizotinib among patients with previously untreated advanced anaplastic lymphoma kinase (ALK)-positive non-small cell lung cancer (NSCLC).

Methods: A matching-adjusted indirect comparison method was implemented to adjust for cross-trial differences in patient characteristics between ASCEND-4 and PROFILE 1014 trials. Patient-level data from ASCEND-4 and published summary data from PROFILE 1014 were used. Patients in ASCEND-4 were reweighted to match average baseline characteristics (i.e. age, sex, race, tumor histology, ECOG score, smoking status, extent of disease, and presence of brain metastases) reported for PROFILE 1014 patients using propensity score weighting. PFS and OS were then compared between balanced populations.

Results: ASCEND-4 included more current smokers (8.0% vs 4.4%) and fewer patients under the age of 65 years (78.5% vs 84.0%) compared to PROFILE 1014. After matching, these and all other patient characteristics were balanced between the two trial populations. Compared to crizotinib, ceritinib was associated with a significantly longer PFS (hazard ratio [95% confidence interval] (HR [CI])?=?0.64 [0.47–0.87]; median PFS: 25.2 vs 10.8 months, log-rank p-value?=?0.003). OS did not differ significantly, with a HR of 0.82 [0.54–1.27] for ceritinib compared to crizotinib.

Conclusions: In the adjusted indirect comparison with external controls, the second generation ALK inhibitor, ceritinib, was associated with a significantly prolonged PFS compared to crizotinib as first-line treatment for ALK-positive NSCLC.     

肉桂鞣质B-1对脊髓星形胶质细胞增殖的调节作用及对血清氧葡萄糖缺乏/复氧诱导细胞凋亡的保护作用

背景背景:中枢神经系统中星形胶质细胞对神经元起重要的保护作用。据报道,一些抗氧化剂可以保护缺血/再灌注引起的星形胶质细胞功能障碍。肉桂鞣质B-1(Cinnamtannin B-1)是一种天然存在的A型原花青素,具有抗氧化作用。目的:研究肉桂鞣质B-1对脊髓星形胶质细胞的作用。方法:星形胶质细胞血清氧葡萄糖缺乏(OGSD)8 h后用或不用肉桂鞣质B-1进行复氧(R)。结果结果:肉桂鞣质B-1对OGSD/R诱导的星形胶质细胞凋亡具有保护作用,同时具有促进星形胶质细胞增殖的作用,而细胞外调节蛋白激酶(ERK)抑制剂逆转这种作用。结论结论:肉桂鞣质B-1通过ERK信号通路促进星形胶质细胞增殖,保护OGSD/R诱导的细胞凋亡。在中枢神经系统,肉桂鞣质B-1作为一种抗氧化剂对星形胶质细胞缺血/再灌注损伤具有保护作用。     

中医骨伤手法联合中药内服对颈椎病的效果分析

目的探讨中医骨伤手法联合中药内服对颈椎病的临床治疗效果。方法以我院2016年4月—2017年4月收治的112例颈椎病患者为研究对象,根据不同疗法分为观察组和对照组,每组56例,观察组给予中医骨伤手法联合中药内服治疗,对照组给予中药内服治疗,对比分析两组患者临床疗效及治疗前后患者头痛、恶心、呕吐、眩晕等症状发生情况。结果治疗结果显示,观察组患者临床治疗总有效率为96.4%,显著高于对照组的78.6%(χ~2=8.16,P0.05);两组患者经治疗后头痛、恶心、呕吐、眩晕等症状均得到改善,观察组临床症状改善情况显著优于对照组,差异具有统计学意义(t=4.92,7.66,5.30;P0.05)。结论中医骨伤手法联合中药内服治疗颈椎病疗效显著,能显著改善患者临床症状,安全可靠值得临床推广。     

Brain proteomic differences between wild-type and CD44- mice induced by chronic Toxoplasma gondii infection

Parasitology Research - Chronic clinical Toxoplasma gondii (T. gondii) infection is the primary disease state that causes severe encephalitis. CD44 is a member of the cell adhesion molecule family...     

Molecular detection and genetic diversity of Theileria orientalis in cattle in China

Parasitology Research - The apicomplexan parasite Theileria orientalis is a tick-borne intracellular protozoan parasite that is widely distributed throughout China. It causes bovine theileriosis in...     

某大型儿童医院医用耗材供应链管理实践

目的：为解决医院医用耗材采购、管理中存在的问题,在某大型儿童医院构建医用耗材供应链平台。方法：医院采用先进的现代物流理念,建立医用耗材供应链信息平台,引入第三方院内物流服务,创新性地在全院所有临床、医技科室耗材消耗终端设立智能二级库体系,打造医院、供应商、运营商集申请、采购、仓储、配送及追溯一体化的全智能物流服务模式。结果：医用耗材供应链平台上线后,全面实现了互联网智能化流程,减少了医院人员的投入成本,提升了医院医用耗材的物流管理水平。同时,先使用后结算的模式,减少资金占用;耗材消耗数据实时采集,使财务对账流程更优化。耗材全流程条码化配送,为全闭环的追溯管理提供了支撑。设立耗材字典库,解决过去同一耗材不同名称,不同注册证导致的系统检索、分类困难等问题。耗材字典编码与HIS系统、医保、物价编码建立一一对应的关系,确保收费信息准确采集。结论：医用耗材供应链平台实现内外物流一体化整合,B2B供应商云平台全面实现“互联网 + 采购”;SPD运营服务平台提升物流效率,降低物流成本,让医疗资源更好回归患者;第三方院内物流服务全面提升临床满意度;院内精细化管理深度打造全流程闭环管控,耗材运营数据分析为管理者提供决策支撑。